Clinical Trials Browser

Lung Neoplasms × Tyrosine Kinase Inhibitors × 1 year × Clear all

NCT03611738 2026-05-15

Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC

Phase 1 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms